Literature DB >> 33087448

Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum.

Kazuyoshi Michiba1, Kazuya Maeda2, Ko Kurimori1, Tsuyoshi Enomoto1, Osamu Shimomura1, Tomoyo Takeuchi1, Hiroyuki Nishiyama1, Tatsuya Oda1, Hiroyuki Kusuhara2.   

Abstract

Intestinal permeability is a critical factor for orally administered drugs. It can be facilitated by uptake transporters or limited by efflux transporters and metabolic enzymes in the intestine. The present study aimed to characterize the Ussing chamber system incorporating human intestinal tissue as an in vitro model for investigating the impact of intestinal uptake/efflux transporters on the intestinal absorption of substrate drugs in humans. We confirmed the functions of major intestinal uptake/efflux drug transporters in freshly isolated human jejunum sections by demonstrating a significant decrease in the mucosal uptake of cefadroxil (peptide transporter 1) and methotrexate (proton-coupled folate transporter), mucosal-to-serosal permeability of ribavirin (concentrative nucleoside transporters/equilibrative nucleoside transporters), and serosal-to-mucosal permeability of P-glycoprotein and breast cancer resistance protein substrates in the presence of their typical inhibitors. The mucosal-to-serosal apparent permeability coefficients (Papp) of 19 drugs, including substrates of drug transporters and cytochrome P450 3A, ranged from 0.60 × 10-6 to 29 × 10-6 cm/s and showed a good correlation with reported fraction of an oral dose that enters the gut wall and passes into the portal circulation with escaping intestinal metabolism (FaFg) values in humans. Furthermore, the Papp values for cefadroxil, methotrexate, and ribavirin in the presence of the corresponding transporter inhibitors underestimated the FaFg of these drugs, which clearly showed that intestinal uptake transporters facilitate their intestinal absorption in humans. In conclusion, the functions of major intestinal uptake/efflux drug transporters could be maintained in freshly isolated human jejunum sections. The Ussing chamber system incorporating human intestinal tissue would be useful for evaluating the impact of intestinal uptake/efflux transporters on the intestinal absorption of various types of drugs in humans. SIGNIFICANCE STATEMENT: Although previous studies have predicted the intestinal absorption of drugs in humans using the Ussing chamber system incorporating human intestinal tissue, there is little systematic information about drug transport mediated by multiple transporters in this system. We confirmed the functions of major intestinal uptake/efflux transporters in freshly isolated human jejunum sections and demonstrated that the mucosal-to-serosal apparent permeability coefficient of various types of drugs showed a good correlation with reported human FaFg values.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33087448     DOI: 10.1124/dmd.120.000138

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  4 in total

1.  A proof of concept using the Ussing chamber methodology to study pediatric intestinal drug transport and age-dependent differences in absorption.

Authors:  Eva J Streekstra; Márton Kiss; Jeroen van den Heuvel; Johan Nicolaï; Petra van den Broek; Sanne M B I Botden; Martijn W J Stommel; Lara van Rijssel; Anna-Lena Ungell; Evita van de Steeg; Frans G M Russel; Saskia N de Wildt
Journal:  Clin Transl Sci       Date:  2022-08-12       Impact factor: 4.438

Review 2.  Gutsy science: In vitro systems of the human intestine to model oral drug disposition.

Authors:  Christopher M Arian; Tomoki Imaoka; Jade Yang; Edward J Kelly; Kenneth E Thummel
Journal:  Pharmacol Ther       Date:  2021-08-31       Impact factor: 12.310

3.  Ca2+-Permeable Channels/Ca2+ Signaling in the Regulation of Ileal Na+/Gln Co-Transport in Mice.

Authors:  Fenglan Chu; Hanxing Wan; Weidong Xiao; Hui Dong; Muhan Lü
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

4.  Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1.

Authors:  Olga Hartwig; Brigitta Loretz; Adrien Nougarede; Dorothée Jary; Eric Sulpice; Xavier Gidrol; Fabrice Navarro; Claus-Michael Lehr
Journal:  J Control Release       Date:  2022-03-23       Impact factor: 11.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.